| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.71▼ | 1.70▼ | 1.70▼ | 1.63▲ | 1.80▼ |
| MA10 | 1.72▼ | 1.72▼ | 1.72▼ | 1.65▲ | 2.10▼ |
| MA20 | 1.66▲ | 1.64▲ | 1.64▲ | 1.80▼ | 1.93▼ |
| MA50 | 1.70▲ | 1.74▼ | 1.76▼ | 1.99▼ | 1.69▲ |
| MA100 | 1.83▼ | 1.85▼ | 1.88▼ | 1.95▼ | 1.13▲ |
| MA200 | 1.92▼ | 2.08▼ | 2.12▼ | 1.92▼ | 1.42▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | 0.015▲ | 0.018▲ | -0.006▼ | -0.071▼ |
| RSI | 51.811▲ | 50.739▲ | 50.348▲ | 42.415▼ | 46.731▼ |
| STOCH | 36.327 | 43.182 | 57.492 | 30.403 | 43.712 |
| WILL %R | -43.902 | -32.143 | -32.143 | -62.712 | -66.026 |
| CCI | -11.543 | 30.925 | 34.267 | -13.650 | -75.614 |
| CDL | $INAB Doji Candlestick Pattern Detected | Set Alert |
|
Friday, February 27, 2026 04:46 AM
About IN8bio Inc. IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tu ...
|
|
Tuesday, February 24, 2026 05:58 AM
IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies for cancer and autoimmune diseases, today announced that William Ho, CEO ...
|
|
Monday, February 09, 2026 05:17 AM
Photo Kate Rochlin, Ph.D., President & COO NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- IN8bio (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ ) T cell ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/02/26 | 1.69 | 1.7999 | 1.66 | 1.70 | 43,016 |
| 26/02/26 | 1.68 | 1.81 | 1.68 | 1.71 | 23,383 |
| 25/02/26 | 1.60 | 1.7199 | 1.5901 | 1.66 | 16,618 |
| 24/02/26 | 1.53 | 1.59 | 1.51 | 1.55 | 20,292 |
| 23/02/26 | 1.54 | 1.60 | 1.50 | 1.51 | 0 |
| 20/02/26 | 1.63 | 1.69 | 1.48 | 1.55 | 59,157 |
| 19/02/26 | 1.67 | 1.68 | 1.58 | 1.60 | 51,587 |
| 18/02/26 | 1.73 | 1.7899 | 1.66 | 1.68 | 34,102 |
| 17/02/26 | 1.75 | 1.79 | 1.72 | 1.72 | 42,003 |
| 13/02/26 | 1.814 | 1.90 | 1.78 | 1.78 | 29,567 |
|
|
||||
|
|
||||
|
|